← All published screens
Highest ROE in Healthcare
Snapshot from 2026-08-06 · 25 stocks
Sector is Healthcare
| Ticker | Name | Sector | Price | Market Cap | P/E | P/B | ROE | Gross Margin |
|---|---|---|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics, Inc. - Common Stock | Healthcare | $83.59 | $9.91B | 31.29 | 45.14 | 144.3% | — |
| AUPH | Aurinia Pharmaceuticals Inc - Common Shares | Healthcare | $15.19 | $1.95B | 6.80 | 3.44 | 50.6% | — |
| EXEL | Exelixis, Inc. - Common Stock | Healthcare | $56.70 | $14.25B | 18.21 | 7.36 | 40.4% | — |
| ALNY | Alnylam Pharmaceuticals, Inc. - Common Stock | Healthcare | $228.72 | $30.33B | 96.68 | 38.44 | 39.8% | — |
| TMDX | TransMedics Group, Inc. - Common Stock | Healthcare | $76.49 | $2.64B | 13.89 | 5.35 | 38.5% | — |
| CRMD | CorMedix Inc. - Common Stock | Healthcare | $7.41 | $581.33M | 3.57 | 1.33 | 37.3% | — |
| TBPH | Theravance Biopharma Inc | Healthcare | $16.90 | $871.25M | 8.23 | 3.00 | 36.4% | — |
| GILD | Gilead Sciences, Inc. - Common Stock | Healthcare | $131.76 | $163.59B | 19.22 | 6.96 | 36.2% | — |
| BMY | Bristol-Myers Squibb Company Common Stock | Healthcare | $63.63 | $129.94B | 18.42 | 6.47 | 35.2% | — |
| NVS | Novartis AG Common Stock | Healthcare | $154.44 | $294.69B | 21.07 | 6.39 | 30.3% | — |
| DXCM | DexCom, Inc. - Common Stock | Healthcare | $82.66 | $31.90B | 38.14 | 10.79 | 28.3% | — |
| IRMD | iRadimed Corporation - Common Stock | Healthcare | $91.86 | $1.17B | 52.24 | 11.92 | 22.8% | — |
| UTHR | United Therapeutics Corporation - Common Stock | Healthcare | $519.01 | $22.03B | 16.51 | 3.73 | 22.6% | — |
| EHC | Encompass Health Corporation Common Stock | Healthcare | $110.90 | $11.00B | 19.43 | 4.36 | 22.5% | — |
| RMD | ResMed Inc. Common Stock | Healthcare | $224.03 | $32.50B | 23.20 | 5.01 | 21.6% | — |
| CPRX | Catalyst Pharmaceuticals, Inc. - Common Stock | Healthcare | $31.49 | $3.85B | 17.98 | 3.81 | 21.2% | — |
| OGN | Organon & Co. Common Stock | Healthcare | $13.57 | $3.56B | 19.06 | 3.95 | 20.7% | — |
| MSA | MSA Safety Incorporated Common Stock | Healthcare | $192.81 | $7.44B | 26.69 | 5.49 | 20.6% | — |
| VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | Healthcare | $484.83 | $123.05B | 31.13 | 6.36 | 20.4% | — |
| INVA | Innoviva, Inc. - Common Stock | Healthcare | $20.51 | $1.51B | 5.58 | 1.13 | 20.2% | — |
| COLL | Collegium Pharmaceutical, Inc. - Common Stock | Healthcare | $35.74 | $1.16B | 18.44 | 3.71 | 20.1% | — |
| MDXG | MiMedx Group, Inc - Common Stock | Healthcare | $4.16 | $619.61M | 12.76 | 2.55 | 20.0% | — |
| UHS | Universal Health Services, Inc. Common Stock | Healthcare | $171.66 | $11.07B | 7.43 | 1.48 | 19.9% | — |
| LNTH | Lantheus Holdings, Inc. - Common Stock | Healthcare | $101.50 | $6.61B | 28.29 | 5.45 | 19.3% | — |
| PODD | Insulet Corporation - Common Stock | Healthcare | $133.26 | $9.23B | 37.35 | 7.09 | 19.0% | — |